SSR 16-4p: Titles II and XVI: Using Genetic Test Results to Evaluate Disability

FederalRulings

Ask Donna

How this section applies to your facts.

Social Security Rulings › DI › Disability Insurance — Medical › SSR 16-4p

This text was captured on Aug 14, 2026. It is a snapshot, not a live feed, so check the official code before relying on it.

Text

Effective Date: April 13, 2016 Federal Register

Vol. 81, No. 71, page 21944 Corrected by Federal

Register Vol. 81, No. 77, page 23543

Policy Interpretation Ruling

PURPOSE: This SSR explains how we consider medical

evidence containing the results of genetic tests and helps adjudicators,

including disability examiners and medical and psychological

consultants, consistently apply our policies in disability

claims. [1]

CITATIONS: Sections 216(i) , 223(d) , 223(f) , 1614(a)(3) and 1614(a)(4) of the Social Security Act, as amended; 20 CFR Part 401; 20 CFR 401.55 , 404.1505 , 404.1508 , 404.1512 , 404.1513 , 404.1519a , 404.1519m , 404.1520 , 404.1520b , 404.1527 , 404.1528 , 404.1529 , 404.1545 , 416.905 , 416.906 , 416.908 , 416.911 , 416.912 , 416.913 , 416.919a , 416.919m , 416.920 , 416.920b , 416.924 , 416.924a , 416.926a , 416.927 , 416.928 , 416.929 ,

and 416.945 ;

and 20 CFR

Part 404, appendix 1 .

INTRODUCTION: In all claims for disability, we need objective medical

evidence to establish the existence of a medically determinable

impairment (MDI). Genetic test results sometimes are a part of this

objective medical evidence and can also be of value at other points in

the sequential evaluation process. In this ruling, we provide basic

information about genetic testing and clarify how we apply our policies

when evaluating genetic test results found in the medical evidence of

record (MER).

nce of a medically determinable

impairment (MDI). Genetic test results sometimes are a part of this

objective medical evidence and can also be of value at other points in

the sequential evaluation process. In this ruling, we provide basic

information about genetic testing and clarify how we apply our policies

when evaluating genetic test results found in the medical evidence of

record (MER).

POLICY INTERPRETATION: We consider all medical evidence, including

genetic test results, when evaluating a claim for disability benefits.

The information that follows is presented in question and answer format

and provides details about medical genetics and how to consider MER

containing genetic test results under our disability policy. Questions

1 through 3 provide basic background information about genetic tests and

their use in the medical setting. Question 4 discusses the relevance of

genetic test results to our disability program. Question 5 discusses

whether genetic test results alone are sufficient to make a disability

determination. Question 6 clarifies that we do not purchase genetic

testing. Questions 7 through 11 specify how adjudicators should handle

evidence containing genetic test results at various points of the

adjudication process. Question 12 addresses our policy on the

disclosure of genetic information.

List of Questions

- What is genetic

testing?

- How do genetic

variants relate to medical disorders?

- Why do medical

professionals order genetic tests?

- Why are genetic

tests relevant to us?

- Are genetic test

results alone sufficient to make a disability determination or

decision?

- Will we purchase

genetic testing by way of consultative examination (CE)?

- Do we consider

medical evidence that includes the results of genetic tests?

- Do we require

genetic test results to find a claimant disabled?

- Who typically provides

genetic test evidence?

- Can we consider

genetic test results in the sequential evaluation process?

disability determination or

decision?

- Will we purchase

genetic testing by way of consultative examination (CE)?

- Do we consider

medical evidence that includes the results of genetic tests?

- Do we require

genetic test results to find a claimant disabled?

- Who typically provides

genetic test evidence?

- Can we consider

genetic test results in the sequential evaluation process?

- If a person is

found disabled, can we use genetic test results when setting a diary for

continuing disability review (CDR)?

- What is our policy

regarding the disclosure of the results of genetic tests?

What is genetic

testing?

How do genetic

variants relate to medical disorders?

Why do medical

professionals order genetic tests?

Why are genetic

tests relevant to us?

Are genetic test

results alone sufficient to make a disability determination or

decision?

Will we purchase

genetic testing by way of consultative examination (CE)?

Do we consider

medical evidence that includes the results of genetic tests?

Do we require

genetic test results to find a claimant disabled?

Who typically provides

genetic test evidence?

Can we consider

genetic test results in the sequential evaluation process?

If a person is

found disabled, can we use genetic test results when setting a diary for

continuing disability review (CDR)?

What is our policy

regarding the disclosure of the results of genetic tests?

Answers

ire

genetic test results to find a claimant disabled?

Who typically provides

genetic test evidence?

Can we consider

genetic test results in the sequential evaluation process?

If a person is

found disabled, can we use genetic test results when setting a diary for

continuing disability review (CDR)?

What is our policy

regarding the disclosure of the results of genetic tests?

Answers

- What is genetic testing? [2] Genetic testing is a type of medical

test that identifies variations in genetic material. Genetic testing

uses laboratory methods to detect genetic variations associated with a

disease, condition, or genetic disorder. For the purposes of this

ruling, we will consider tests that analyze chromosomes , deoxyribonucleic acid (DNA), or ribonucleic acid (RNA) for

the purpose of identifying congenital genetic variations to be genetic

tests. [3] Different types of laboratory tests constitute genetic tests.

For example, karyotyping , which counts and examines the

appearance of chromosomes in a cell, is a type of genetic test. Some

other types of genetic tests read and evaluate the sequence of the

nucleotide bases that make up a DNA molecule or examine changes at one

specific place in the genome. Differences from the normal (or

reference) sequence are known as mutations or variants. Variants also

encompass partial or complete loss or gain of gene copies.

- How do genetic variants relate to

medical disorders? People generally have two copies of every gene in their body, one

contributed by their biological mother, the other contributed by their

biological father. Some disorders are caused by a variation in a single

gene. In certain cases, having a variation in just one of the two

copies of the gene is enough to lead to a disorder. If a variant's

occurrence in only one copy of the gene is sufficient for a person to

develop the disorder, the disorder is dominant

contributed by their biological mother, the other contributed by their

biological father. Some disorders are caused by a variation in a single

gene. In certain cases, having a variation in just one of the two

copies of the gene is enough to lead to a disorder. If a variant's

occurrence in only one copy of the gene is sufficient for a person to

develop the disorder, the disorder is dominant . The disorder is recessive if an associated variant must occur in both copies of

the gene for a person to develop the disorder. Even when a person knows that he or she has a genetic variant

associated with or causative of a certain disorder, he or she may not

always develop the condition. Penetrance is the term that

describes the frequency with which people in a population with a given

genetic variant actually display signs and symptoms of the associated

disorder. It is often expressed as a percentage. Complete

penetrance indicates that all people in a population with the

genetic variant will develop the disorder. Incomplete or reduced penetrance , which is far more common, means that only

some people in a population with the variant will actually get the

disorder. The probability that a given person will have a disorder

given that they have the variant is known as risk or chance . Variants can interact either with one another or with environmental

influences (such as ultraviolet light, diet, or smoking) to result in a

disorder. These types of disorders are called complex or multifactorial disorders. Even when genetic variants associated

with complex disorders are known, it may be difficult to determine the

risk of developing such disorders based on genetic test results. For

example, changes in a person's exposure to relevant environmental

influences can modify the risk of developing a disease or the severity

of a genetic condition. Chromosomal abnormalities can lead to disorders as well. A

chromosome is an organized package of DNA located in the nucleus of a

cell

be difficult to determine the

risk of developing such disorders based on genetic test results. For

example, changes in a person's exposure to relevant environmental

influences can modify the risk of developing a disease or the severity

of a genetic condition. Chromosomal abnormalities can lead to disorders as well. A

chromosome is an organized package of DNA located in the nucleus of a

cell. People generally have 2 copies of each of 23 chromosomes in their

cells. Aneuploidy means an incorrect number of chromosomes.

Down syndrome is an example of a genetic disorder caused by aneuploidy.

It is the result of a person having an extra copy of chromosome 21 in

some or all of his or her cells. A defect in a chromosome's structure

may also cause a genetic condition. Cri du chat syndrome is an example

of a disorder that results from a structural chromosomal abnormality.

It is due to one chromosome 5 missing a part.

- Why do medical professionals order

genetic tests? Like other laboratory tests or procedures, genetic tests can help

medical professionals diagnose a particular disease or disorder. They

assist in predicting the extent of disease features or risk of

developing a certain disorder, aid in therapy, and provide useful

information for reproductive purposes. Diagnostic tests Medical professionals may use genetic tests to diagnose a particular

disorder. They will usually order or perform these tests when a person

has medical signs or symptoms consistent with that disorder and a link

between specific genetic variations and the disorder is

well-characterized. They may also use testing when a disorder is

present but unrecognized (or undiagnosed) to work through a list of

possibilities, i.e., differential diagnoses. Such tests are known as diagnostic genetic tests. Hemochromatosis is an example of a

disease for which medical professionals use a diagnostic genetic test to

help confirm a diagnosis

tic variations and the disorder is

well-characterized. They may also use testing when a disorder is

present but unrecognized (or undiagnosed) to work through a list of

possibilities, i.e., differential diagnoses. Such tests are known as diagnostic genetic tests. Hemochromatosis is an example of a

disease for which medical professionals use a diagnostic genetic test to

help confirm a diagnosis. [4] Predictive tests A person might choose to have a genetic test even if he or she does

not have medical signs or symptoms indicative of a disorder. Instead,

he or she may undergo testing to find out whether he or she has a

genetic variant that might put him or her at risk for developing a

disorder in the future. This type of test is a predictive genetic test. A positive predictive test result may result in a

pre-symptomatic diagnosis of a genetic condition, or just knowledge of

an increased risk of developing that condition. Examples of predictive

genetic tests are those looking for variations in the genes BRCA1 and BRCA2 , which assess a person's risk for certain inherited

breast and ovarian cancer syndromes. [5] It is important to note that, for many conditions, predictive genetic

tests cannot tell with certainty whether a person will develop a

disorder. The results of predictive genetic tests generally give a

probability or range of probabilities that a disorder will eventually

develop in the person being tested. Predictive genetic tests also

generally cannot tell a person precisely how the disorder will affect

him or her. Many times, predictive genetic testing is most helpful when

a person has a known family history of a disease, and not knowing the

disease risk would lead to serious consequences. A person may choose to

undergo predictive genetic testing to make decisions about future

medical care or to implement lifestyle changes to help mitigate

potential risk for adverse health effects

l affect

him or her. Many times, predictive genetic testing is most helpful when

a person has a known family history of a disease, and not knowing the

disease risk would lead to serious consequences. A person may choose to

undergo predictive genetic testing to make decisions about future

medical care or to implement lifestyle changes to help mitigate

potential risk for adverse health effects. Pharmacogenetic tests Medical professionals might order pharmacogenetic tests for a

patient who needs to receive pharmaceutical therapy for his or her

disorder. The information from this kind of genetic test can help

medical staff understand how a patient may react to a particular drug

and assist in selection of the safest, most effective type and dosage of

medicine for that specific person. Tests for reproductive purposes There are genetic tests that people obtain prior to having a child in

order to inform them about the potential for a genetic disorder in their

child. These reproductive genetic tests include carrier tests, prenatal tests, and predictive tests for a late-onset

dominant disorder in an at-risk parent. [6] Carrier genetic tests are

performed on people who display no symptoms for a genetic disorder but

may be at risk for passing it on to their children. Diagnostic prenatal

genetic tests show if the developing baby has a certain genetic

condition. A parent with a family history of a genetic disorder with

dominant inheritance that does not manifest until after childbearing

years may wish to get a predictive genetic test for that disorder to

understand the risk of passing that disorder to his or her child.

k for passing it on to their children. Diagnostic prenatal

genetic tests show if the developing baby has a certain genetic

condition. A parent with a family history of a genetic disorder with

dominant inheritance that does not manifest until after childbearing

years may wish to get a predictive genetic test for that disorder to

understand the risk of passing that disorder to his or her child.

- Why are genetic tests relevant

to us? Scientific researchers are discovering an increasing number of

associations between genetic variants and medical disorders. [7] With this

knowledge often comes the ability to perform a laboratory test to

determine whether a person carries a genetic variation associated with a

particular disorder. There are tens of thousands of genetic tests

available for clinical use and the number continues to grow. These

tests can identify thousands of genetic disorders. [8] The results of such

tests may appear in disability case records. Genetic tests are more

widely available and genetic test results are now more commonplace

within disability case files.

- Are genetic test results alone

sufficient to make a disability determination or decision? With the sole exception of non-mosaic Down syndrome, genetic test

results alone are not sufficient to make a disability determination or

decision. A person may be found disabled based on meeting the criteria

for non-mosaic Down syndrome in the Listing of Impairments (listings)

under 10.06A and 110.06A, when this condition is documented by a

karyotype report signed by a physician. [9] Genetic test results alone are

otherwise not sufficient to make a disability determination; however, in

two other medical listings, we use genetic test results as part of the

criteria to evaluate whether a person's impairment meets the listing. [10] Additional evidence, including signs and symptoms of a person's

impairment, is generally necessary to make a disability determination

ysician. [9] Genetic test results alone are

otherwise not sufficient to make a disability determination; however, in

two other medical listings, we use genetic test results as part of the

criteria to evaluate whether a person's impairment meets the listing. [10] Additional evidence, including signs and symptoms of a person's

impairment, is generally necessary to make a disability determination.

As genetic testing continues to advance, we will consider appropriate

changes to our program policy.

- Will we purchase genetic testing

by way of consultative examination (CE)? No. We will not order genetic testing in a CE. While genetic test

results may provide valuable information when they appear as part of a

large body of MER, they are not necessary to establish a finding of

disability.

- Do we consider medical evidence that

includes the results of genetic tests? Yes, we consider all evidence we receive, including genetic test

results, when evaluating a disability claim. [11] In considering a

disability claim, we generally request evidence about a person's medical

impairment(s) for a period of at least the 12 months (and a longer

duration if circumstances warrant) preceding the month in which a person

files an application. [12] This includes objective medical evidence, a

claimant's reported symptoms, statements from others about the effects

of the claimant's impairment(s), and opinion evidence. [13] The results of genetic tests constitute laboratory findings, which

are considered objective medical evidence. Consistent with our

regulations, when genetic test results are available, we will consider

them, together with all relevant evidence available in the case record,

such as signs, symptoms, other laboratory findings, and medical opinion

evidence. [14] When evidence is inconsistent, such as when genetic test

results are inconsistent with other substantial evidence, we will

resolve the inconsistency when it is material to the disability

determination, as we do with all medical evidence

them, together with all relevant evidence available in the case record,

such as signs, symptoms, other laboratory findings, and medical opinion

evidence. [14] When evidence is inconsistent, such as when genetic test

results are inconsistent with other substantial evidence, we will

resolve the inconsistency when it is material to the disability

determination, as we do with all medical evidence. [15]

- Do we require genetic test results

to find a claimant disabled? No, genetic test results are not required for a finding of

disability. A finding of disability requires a claimant to have an MDI,

which can be expected to result in death or which has lasted or can be

expected to last for a continuing period of not less than 12 months. [16] We

establish physical and mental impairments by medical evidence consisting

of signs, symptoms, and laboratory findings. [17] While several medical

listings require or reference the use of genetic test results as a way

to meet the applicable listing at step 3 of the sequential evaluation

process, [18] our rules do not require the results of genetic tests in order

to determine that a person is disabled.

- Who typically provides genetic test

evidence? We typically receive the results of genetic tests in medical evidence

from clinical geneticists, other physicians, and genetic counselors.

Claimants sometimes provide results of “direct-to-consumer”

(DTC) medical tests. We will consider genetic test results from all

sources, medical and otherwise. [19] Geneticists and other physicians Clinical geneticists are physicians specializing in the diagnosis

and management of hereditary disorders. Clinical geneticists and other

licensed physicians have a medical degree and are acceptable medical

sources (AMS). We establish the existence of an MDI using objective

medical evidence (signs or laboratory results) from an AMS.

Cytogeneticists, biochemical geneticists, and molecular geneticists may

hold a Ph.D. or a medical degree (e.g., M.D

diagnosis

and management of hereditary disorders. Clinical geneticists and other

licensed physicians have a medical degree and are acceptable medical

sources (AMS). We establish the existence of an MDI using objective

medical evidence (signs or laboratory results) from an AMS.

Cytogeneticists, biochemical geneticists, and molecular geneticists may

hold a Ph.D. or a medical degree (e.g., M.D. or D.O.); those without a

medical degree are generally not AMSs. For example, Ph.D.

cytogeneticists typically work in laboratories or act as clinical

consultants, but do not regularly interact with patients. These types

of geneticists may be involved in obtaining genetic testing results and

may be board-certified, but they are not AMSs if they are not also

licensed physicians or otherwise classified as an AMS. Genetic counselors Genetic counselors assess and communicate genetic risk for medical

conditions in a person and members of his or her biological family.

They obtain and evaluate personal and family medical histories as well

as identify and coordinate genetic tests and other diagnostic studies,

as appropriate, to obtain needed information for a genetic assessment.

They are also able to explain the clinical implications of genetic

laboratory tests and other diagnostic studies and their results. [20] These professionals typically hold a master's degree in Genetic

Counseling and may be board-certified by the American Board of Genetic

Counseling (denoted by the use of the credential “Certified

Genetic Counselor” or CGC). However, we do not consider a genetic

counselor to be an AMS under our rules unless the individual is also a

licensed physician or other AMS provider. This is true even when the

genetic counselor is licensed to practice genetic counseling by his or

her State. We cannot establish the existence of an MDI based solely on

a report from a genetic counselor

l “Certified

Genetic Counselor” or CGC). However, we do not consider a genetic

counselor to be an AMS under our rules unless the individual is also a

licensed physician or other AMS provider. This is true even when the

genetic counselor is licensed to practice genetic counseling by his or

her State. We cannot establish the existence of an MDI based solely on

a report from a genetic counselor. We can use evidence from genetic

counselors working in an independent capacity to show the severity of a

person's impairment and how it affects the person's ability to work, or,

for children, how the child typically functions compared to children of

the same age who do not have impairments. [21] “Direct-to-consumer” (DTC) tests DTC genetic tests are available and appear to be growing in

popularity. These tests are generally marketed directly to consumers

via television, print advertisements, or the internet. A person

typically collects a DNA sample at home, such as by swabbing the inside

of the cheek, and mails the sample back to the laboratory for testing.

In some cases, the person must visit a health clinic to have blood

drawn. The samples are analyzed and consumers are directly notified of

the results by mail, over the telephone, or online. [22] There is currently little regulation and oversight of DTC genetic

testing, leading to concerns about its accuracy, reliability, and

clinical relevance. [23] DTC services generally do not establish an

appropriate chain of custody of the DNA sample. There is no assurance

that DTC genetic test results belong to a given claimant, as the entire

transaction typically takes place with no personal interaction with a

medical source or without any type of oversight that confirms the

identity of the person providing the sample. For these reasons, DTC

genetic test results cannot be the basis for establishing an MDI,

regardless of AMS adoption or involvement

assurance

that DTC genetic test results belong to a given claimant, as the entire

transaction typically takes place with no personal interaction with a

medical source or without any type of oversight that confirms the

identity of the person providing the sample. For these reasons, DTC

genetic test results cannot be the basis for establishing an MDI,

regardless of AMS adoption or involvement. [24] Nevertheless, DTC results,

when consistent with independent credible objective medical evidence,

can help corroborate other findings or the claimant's allegations. [25]

- Can we consider genetic test

results in the sequential evaluation process? Yes, we consider genetic test results and all other evidence in

varying ways throughout the sequential evaluation process. [26] At step 2 we

establish whether a person has an MDI and whether the impairment or

combination of impairments is severe, i.e., whether it significantly

limits the physical or mental ability to do basic work activities. [27] Information from genetic test results can help establish an MDI if they

are from an AMS and not based on DTC test results. However, a genetic

test alone cannot typically show whether or not an impairment is severe.

At step 3 we consider whether the impairment meets or medically equals

the requirements of a listed impairment in the medical listings.

Several of our medical listings include criteria that require

appropriate genetic test results for an impairment to meet the listing. [28] If a person's MDI does not meet or medically equal a listing, we

assess whether the impairment(s) results in functional limitations that

would prevent him or her from performing past relevant work or other

work at steps 4 and 5 of sequential evaluation. [29] For children, we assess

whether the impairment(s) causes marked and severe functional

limitations. [30] Genetic test results generally do not provide us with

significant information about impairment severity or functional

capacities

results in functional limitations that

would prevent him or her from performing past relevant work or other

work at steps 4 and 5 of sequential evaluation. [29] For children, we assess

whether the impairment(s) causes marked and severe functional

limitations. [30] Genetic test results generally do not provide us with

significant information about impairment severity or functional

capacities. Can we use genetic test results to establish an MDI (Step 2)? When genetic test results come from an AMS and are not based on DTC

genetic testing, we can use the evidence to establish an MDI if there

are signs and symptoms consistent with the impairment. [31] We can consider

the results of previously-performed genetic testing in establishing an

MDI, if signs and symptoms of an impairment are present. We cannot use

the results of genetic tests, in the absence of any signs or symptoms,

as the sole basis for establishing an MDI, even if the results are

highly- suggestive of the eventual development of an impairment. [32] We

must be able to establish that a person has an MDI at the disability

onset date. Although non-physician geneticists are generally not AMSs, a

physician or other AMS typically reviews or evaluates test results

produced by a non-physician geneticist and incorporates these test

results into an individual's medical record. In such a case, the

evidence can be used to help establish an MDI. Similarly, genetic

counselors are generally not AMSs. Therefore, we cannot establish the

existence of an MDI based solely on a report from a genetic counselor.

However, genetic counselors typically work in a setting where they are

in close collaboration with a physician or other AMS. When a person is

referred for diagnostic testing by a genetic counselor, the results are

often reviewed, evaluated, interpreted, or used by a physician and

incorporated into a medical record. In such a case, this evidence can

help establish an MDI

a genetic counselor.

However, genetic counselors typically work in a setting where they are

in close collaboration with a physician or other AMS. When a person is

referred for diagnostic testing by a genetic counselor, the results are

often reviewed, evaluated, interpreted, or used by a physician and

incorporated into a medical record. In such a case, this evidence can

help establish an MDI. Similar to imaging from an x-ray or MRI, which requires AMS

involvement to establish an MDI, a genetic test result without AMS

involvement cannot establish an MDI. A DTC genetic test result, even if

evaluated, interpreted, or otherwise utilized by an AMS, cannot lead to

the establishment of an MDI because there is no assurance that the test

results belong to a given claimant and no appropriate chain of custody

of the sample is established. Many disorders with a known genetic basis can be, and often are,

established by means other than genetic tests. For example, although

diagnostic genetic tests for cystic fibrosis exist, as do guidelines

surrounding their use, the most common confirmatory test for this

disease is the sweat chloride test, which measures the concentrations of

a certain electrolyte in a person's sweat. [33] It is not a genetic test.

While we consider genetic test results in conjunction with the rest of

the objective medical evidence when they are available, we do not

require a person to undergo such testing to prove they have an MDI or

are disabled. Can we evaluate impairment severity using the results of genetic

tests (Step 2)? To some extent, genetic test results can be helpful in our overall

impairment evaluation, but generally they do not help us determine

whether or not an impairment is severe. For an impairment to be severe,

it must significantly limit an adult's physical or mental ability to do

basic work activities. [34] In the case of a child, for an impairment to be

severe it must be more than a slight abnormality that causes more than

minimal functional limitations

erall

impairment evaluation, but generally they do not help us determine

whether or not an impairment is severe. For an impairment to be severe,

it must significantly limit an adult's physical or mental ability to do

basic work activities. [34] In the case of a child, for an impairment to be

severe it must be more than a slight abnormality that causes more than

minimal functional limitations. [35] Genetic test results generally do not provide information about the

degree of functional limitation associated with an impairment, but they

can be used to help evaluate for consistency with or supportability of

alleged symptoms and limitations. With the exception of non-mosaic Down

Syndrome, we need evidence other than genetic test results to show a

person's impairment is severe. This evidence comes from other medical

records, a claimant's report of symptoms, and statements from nonmedical

sources. [36] Can we evaluate medical listings with genetic test results (Step

3)? For several medical listings, we use genetic test results to evaluate

whether a person's impairment meets a medical listing. Four of our

medical listings include, as part of the criteria for an impairment to

meet a listing, the use of appropriate genetic test results. [37] Listings

10.06 and 110.06 for non-mosaic Down syndrome (trisomy 21) use the

results of genetic tests. Karyotyping for Down syndrome is the

“gold standard” for diagnosis. We typically require the

results of karyotype analysis for an impairment to meet 10.06A, 10.06B,

110.06A, or 110.06B. [38] Additionally, we require diagnostic genetic test

results for xeroderma pigmentosum to meet listing 8.07A or 108.07A. We may also use genetic test results indicating the presence of a

catastrophic congenital disorder, such as Edward's syndrome (trisomy

18), to find a child's impairment meets listing 110.08

of karyotype analysis for an impairment to meet 10.06A, 10.06B,

110.06A, or 110.06B. [38] Additionally, we require diagnostic genetic test

results for xeroderma pigmentosum to meet listing 8.07A or 108.07A. We may also use genetic test results indicating the presence of a

catastrophic congenital disorder, such as Edward's syndrome (trisomy

18), to find a child's impairment meets listing 110.08. Other medical

listings are for disorders, such as cystic fibrosis [39] and chronic

myelogenous leukemia, with at least one known genetic basis and an

available associated test. [40] Often, additional medical evidence is

required to find a person's impairment meets a relevant listing. [41] Can we evaluate the degree of limitation and residual functional

capacity (RFC) using genetic test results (Steps 4 and 5)? While genetic tests may help to establish the presence of a disorder

and assist in determining whether an impairment meets or medically

equals a listing, the results alone generally do not provide us with

information about the degree of a person's limitation due to the

impairment. A claimant's RFC reflects the most he or she can do despite

his or her limitations. [42] If an adult's impairment does not meet or

medically equal a listing at step 3 of the sequential evaluation

process, we assess RFC, which applies to both steps 4 and 5. If a

child's impairment does not meet or medically equal a listing, we assess

functional equivalence. Functional equivalence deals with broad areas

of functioning intended to capture all of what a child can or cannot

do. [43] As is the case with RFC, genetic test results alone generally do not

provide us with information about the degree of limitation as it relates

to functional equivalence. To assess a claimant's impairments beyond step 3, we need non-genetic

evidence about the impairment's effect on a person's functioning to

determine the most the person can do despite his or her limitations and

restrictions

43] As is the case with RFC, genetic test results alone generally do not

provide us with information about the degree of limitation as it relates

to functional equivalence. To assess a claimant's impairments beyond step 3, we need non-genetic

evidence about the impairment's effect on a person's functioning to

determine the most the person can do despite his or her limitations and

restrictions. [44] Many disorders associated with known gene mutations are

multifactorial in nature. Environmental and other influences that are

not well-understood affect the development of medical signs and symptoms

resulting from the disorder and the degree of limitation a person with

the disorder experiences. Therefore, additional evidence is necessary

to adequately assess a person's RFC and ability to engage in work

activities. However, results of genetic tests can be assessed for consistency

with a person's symptoms and alleged limitations. For example, genetic

test results may lead an AMS to diagnose familial Mediterranean fever.

A common symptom is painful inflammation in various areas of the body,

including joints. [45] If someone complains of significant joint pain

and has genetic test results leading to a diagnosis of familial

Mediterranean fever, we can take into account that the claimant's

reported symptoms are consistent with the genetic test results.

- If a person is found disabled,

can we use genetic test results

when setting a diary for continuing disability review (CDR)? Yes. We consider all impairments and case facts to determine when to

conduct a CDR. We conduct a full evaluation of all evidence, including

genetic test results, when setting diary dates. Due to the diversity of

types of genetic tests and the differing types of information that

genetic test results can provide, the impact of genetic test results on

diary lengths will vary.

ility review (CDR)? Yes. We consider all impairments and case facts to determine when to

conduct a CDR. We conduct a full evaluation of all evidence, including

genetic test results, when setting diary dates. Due to the diversity of

types of genetic tests and the differing types of information that

genetic test results can provide, the impact of genetic test results on

diary lengths will vary.

- What is our policy regarding the

disclosure of the results of genetic tests? The Privacy Act of 1974 (5 U.S.C. 552a), section 1106 of the Social

Security Act (42 U.S.C. 1306), and our disclosure regulations ( 20 CFR Part

401 ) govern the collection, maintenance, and use of an individual's

information in our systems of records. Although these authorities do

not specifically address requirements for the disclosure of genetic test

results, they apply to the extent we maintain this type of information

in our records. Under the Privacy Act and our disclosure regulations, we generally

cannot disclose genetic test results without the consent of the subject

of the record. For example, if an individual's MER contains genetic

test results and he or she authorizes us to disclose this specific

information to a third party, we will do so with a valid, written

consent that meets our regulatory requirements. In addition, the Privacy Act grants individuals a right of access to

any records we maintain about them in our systems of records.

Therefore, any genetic test results we maintain in an individual's MER

(including records a medical consultative examiner may have generated on

our behalf) are subject to these access requirements, as is the case

with all medical evidence. However, if we determine that direct access

to the medical information is likely to have an adverse effect on the

subject of the record, we will follow certain procedures in providing

access to the information. [46]

What is genetic testing? [2]

a medical consultative examiner may have generated on

our behalf) are subject to these access requirements, as is the case

with all medical evidence. However, if we determine that direct access

to the medical information is likely to have an adverse effect on the

subject of the record, we will follow certain procedures in providing

access to the information. [46]

What is genetic testing? [2]

Genetic testing is a type of medical

test that identifies variations in genetic material. Genetic testing

uses laboratory methods to detect genetic variations associated with a

disease, condition, or genetic disorder. For the purposes of this

ruling, we will consider tests that analyze chromosomes , deoxyribonucleic acid (DNA), or ribonucleic acid (RNA) for

the purpose of identifying congenital genetic variations to be genetic

tests. [3] Different types of laboratory tests constitute genetic tests.

For example, karyotyping , which counts and examines the

appearance of chromosomes in a cell, is a type of genetic test. Some

other types of genetic tests read and evaluate the sequence of the

nucleotide bases that make up a DNA molecule or examine changes at one

specific place in the genome. Differences from the normal (or

reference) sequence are known as mutations or variants. Variants also

encompass partial or complete loss or gain of gene copies.

How do genetic variants relate to

medical disorders?

People generally have two copies of every gene in their body, one

contributed by their biological mother, the other contributed by their

biological father. Some disorders are caused by a variation in a single

gene. In certain cases, having a variation in just one of the two

copies of the gene is enough to lead to a disorder. If a variant's

occurrence in only one copy of the gene is sufficient for a person to

develop the disorder, the disorder is dominant . The disorder is recessive if an associated variant must occur in both copies of

the gene for a person to develop the disorder.

tion in a single

gene. In certain cases, having a variation in just one of the two

copies of the gene is enough to lead to a disorder. If a variant's

occurrence in only one copy of the gene is sufficient for a person to

develop the disorder, the disorder is dominant . The disorder is recessive if an associated variant must occur in both copies of

the gene for a person to develop the disorder.

Even when a person knows that he or she has a genetic variant

associated with or causative of a certain disorder, he or she may not

always develop the condition. Penetrance is the term that

describes the frequency with which people in a population with a given

genetic variant actually display signs and symptoms of the associated

disorder. It is often expressed as a percentage. Complete

penetrance indicates that all people in a population with the

genetic variant will develop the disorder. Incomplete or reduced penetrance , which is far more common, means that only

some people in a population with the variant will actually get the

disorder. The probability that a given person will have a disorder

given that they have the variant is known as risk or chance .

Variants can interact either with one another or with environmental

influences (such as ultraviolet light, diet, or smoking) to result in a

disorder. These types of disorders are called complex or multifactorial disorders. Even when genetic variants associated

with complex disorders are known, it may be difficult to determine the

risk of developing such disorders based on genetic test results. For

example, changes in a person's exposure to relevant environmental

influences can modify the risk of developing a disease or the severity

of a genetic condition.

isorders are called complex or multifactorial disorders. Even when genetic variants associated

with complex disorders are known, it may be difficult to determine the

risk of developing such disorders based on genetic test results. For

example, changes in a person's exposure to relevant environmental

influences can modify the risk of developing a disease or the severity

of a genetic condition.

Chromosomal abnormalities can lead to disorders as well. A

chromosome is an organized package of DNA located in the nucleus of a

cell. People generally have 2 copies of each of 23 chromosomes in their

cells. Aneuploidy means an incorrect number of chromosomes.

Down syndrome is an example of a genetic disorder caused by aneuploidy.

It is the result of a person having an extra copy of chromosome 21 in

some or all of his or her cells. A defect in a chromosome's structure

may also cause a genetic condition. Cri du chat syndrome is an example

of a disorder that results from a structural chromosomal abnormality.

It is due to one chromosome 5 missing a part.

Why do medical professionals order

genetic tests?

Like other laboratory tests or procedures, genetic tests can help

medical professionals diagnose a particular disease or disorder. They

assist in predicting the extent of disease features or risk of

developing a certain disorder, aid in therapy, and provide useful

information for reproductive purposes.

- Diagnostic tests Medical professionals may use genetic tests to diagnose a particular

disorder. They will usually order or perform these tests when a person

has medical signs or symptoms consistent with that disorder and a link

between specific genetic variations and the disorder is

well-characterized. They may also use testing when a disorder is

present but unrecognized (or undiagnosed) to work through a list of

possibilities, i.e., differential diagnoses. Such tests are known as diagnostic genetic tests

rder or perform these tests when a person

has medical signs or symptoms consistent with that disorder and a link

between specific genetic variations and the disorder is

well-characterized. They may also use testing when a disorder is

present but unrecognized (or undiagnosed) to work through a list of

possibilities, i.e., differential diagnoses. Such tests are known as diagnostic genetic tests. Hemochromatosis is an example of a

disease for which medical professionals use a diagnostic genetic test to

help confirm a diagnosis. [4]

- Predictive tests A person might choose to have a genetic test even if he or she does

not have medical signs or symptoms indicative of a disorder. Instead,

he or she may undergo testing to find out whether he or she has a

genetic variant that might put him or her at risk for developing a

disorder in the future. This type of test is a predictive genetic test. A positive predictive test result may result in a

pre-symptomatic diagnosis of a genetic condition, or just knowledge of

an increased risk of developing that condition. Examples of predictive

genetic tests are those looking for variations in the genes BRCA1 and BRCA2 , which assess a person's risk for certain inherited

breast and ovarian cancer syndromes. [5] It is important to note that, for many conditions, predictive genetic

tests cannot tell with certainty whether a person will develop a

disorder. The results of predictive genetic tests generally give a

probability or range of probabilities that a disorder will eventually

develop in the person being tested. Predictive genetic tests also

generally cannot tell a person precisely how the disorder will affect

him or her. Many times, predictive genetic testing is most helpful when

a person has a known family history of a disease, and not knowing the

disease risk would lead to serious consequences

probability or range of probabilities that a disorder will eventually

develop in the person being tested. Predictive genetic tests also

generally cannot tell a person precisely how the disorder will affect

him or her. Many times, predictive genetic testing is most helpful when

a person has a known family history of a disease, and not knowing the

disease risk would lead to serious consequences. A person may choose to

undergo predictive genetic testing to make decisions about future

medical care or to implement lifestyle changes to help mitigate

potential risk for adverse health effects.

- Pharmacogenetic tests Medical professionals might order pharmacogenetic tests for a

patient who needs to receive pharmaceutical therapy for his or her

disorder. The information from this kind of genetic test can help

medical staff understand how a patient may react to a particular drug

and assist in selection of the safest, most effective type and dosage of

medicine for that specific person.

- Tests for reproductive purposes There are genetic tests that people obtain prior to having a child in

order to inform them about the potential for a genetic disorder in their

child. These reproductive genetic tests include carrier tests, prenatal tests, and predictive tests for a late-onset

dominant disorder in an at-risk parent. [6] Carrier genetic tests are

performed on people who display no symptoms for a genetic disorder but

may be at risk for passing it on to their children. Diagnostic prenatal

genetic tests show if the developing baby has a certain genetic

condition. A parent with a family history of a genetic disorder with

dominant inheritance that does not manifest until after childbearing

years may wish to get a predictive genetic test for that disorder to

understand the risk of passing that disorder to his or her child.

Diagnostic tests

n to their children. Diagnostic prenatal

genetic tests show if the developing baby has a certain genetic

condition. A parent with a family history of a genetic disorder with

dominant inheritance that does not manifest until after childbearing

years may wish to get a predictive genetic test for that disorder to

understand the risk of passing that disorder to his or her child.

Diagnostic tests

Medical professionals may use genetic tests to diagnose a particular

disorder. They will usually order or perform these tests when a person

has medical signs or symptoms consistent with that disorder and a link

between specific genetic variations and the disorder is

well-characterized. They may also use testing when a disorder is

present but unrecognized (or undiagnosed) to work through a list of

possibilities, i.e., differential diagnoses. Such tests are known as diagnostic genetic tests. Hemochromatosis is an example of a

disease for which medical professionals use a diagnostic genetic test to

help confirm a diagnosis. [4]

Predictive tests

A person might choose to have a genetic test even if he or she does

not have medical signs or symptoms indicative of a disorder. Instead,

he or she may undergo testing to find out whether he or she has a

genetic variant that might put him or her at risk for developing a

disorder in the future. This type of test is a predictive genetic test. A positive predictive test result may result in a

pre-symptomatic diagnosis of a genetic condition, or just knowledge of

an increased risk of developing that condition. Examples of predictive

genetic tests are those looking for variations in the genes BRCA1 and BRCA2 , which assess a person's risk for certain inherited

breast and ovarian cancer syndromes. [5]

test is a predictive genetic test. A positive predictive test result may result in a

pre-symptomatic diagnosis of a genetic condition, or just knowledge of

an increased risk of developing that condition. Examples of predictive

genetic tests are those looking for variations in the genes BRCA1 and BRCA2 , which assess a person's risk for certain inherited

breast and ovarian cancer syndromes. [5]

It is important to note that, for many conditions, predictive genetic

tests cannot tell with certainty whether a person will develop a

disorder. The results of predictive genetic tests generally give a

probability or range of probabilities that a disorder will eventually

develop in the person being tested. Predictive genetic tests also

generally cannot tell a person precisely how the disorder will affect

him or her. Many times, predictive genetic testing is most helpful when

a person has a known family history of a disease, and not knowing the

disease risk would lead to serious consequences. A person may choose to

undergo predictive genetic testing to make decisions about future

medical care or to implement lifestyle changes to help mitigate

potential risk for adverse health effects.

Pharmacogenetic tests

Medical professionals might order pharmacogenetic tests for a

patient who needs to receive pharmaceutical therapy for his or her

disorder. The information from this kind of genetic test can help

medical staff understand how a patient may react to a particular drug

and assist in selection of the safest, most effective type and dosage of

medicine for that specific person.

Tests for reproductive purposes

ofessionals might order pharmacogenetic tests for a

patient who needs to receive pharmaceutical therapy for his or her

disorder. The information from this kind of genetic test can help

medical staff understand how a patient may react to a particular drug

and assist in selection of the safest, most effective type and dosage of

medicine for that specific person.

Tests for reproductive purposes

There are genetic tests that people obtain prior to having a child in

order to inform them about the potential for a genetic disorder in their

child. These reproductive genetic tests include carrier tests, prenatal tests, and predictive tests for a late-onset

dominant disorder in an at-risk parent. [6] Carrier genetic tests are

performed on people who display no symptoms for a genetic disorder but

may be at risk for passing it on to their children. Diagnostic prenatal

genetic tests show if the developing baby has a certain genetic

condition. A parent with a family history of a genetic disorder with

dominant inheritance that does not manifest until after childbearing

years may wish to get a predictive genetic test for that disorder to

understand the risk of passing that disorder to his or her child.

Why are genetic tests relevant

to us?

Scientific researchers are discovering an increasing number of

associations between genetic variants and medical disorders. [7] With this

knowledge often comes the ability to perform a laboratory test to

determine whether a person carries a genetic variation associated with a

particular disorder. There are tens of thousands of genetic tests

available for clinical use and the number continues to grow. These

tests can identify thousands of genetic disorders. [8] The results of such

tests may appear in disability case records. Genetic tests are more

widely available and genetic test results are now more commonplace

within disability case files.

Are genetic test results alone

sufficient to make a disability determination or decision?

ilable for clinical use and the number continues to grow. These

tests can identify thousands of genetic disorders. [8] The results of such

tests may appear in disability case records. Genetic tests are more

widely available and genetic test results are now more commonplace

within disability case files.

Are genetic test results alone

sufficient to make a disability determination or decision?

With the sole exception of non-mosaic Down syndrome, genetic test

results alone are not sufficient to make a disability determination or

decision. A person may be found disabled based on meeting the criteria

for non-mosaic Down syndrome in the Listing of Impairments (listings)

under 10.06A and 110.06A, when this condition is documented by a

karyotype report signed by a physician. [9] Genetic test results alone are

otherwise not sufficient to make a disability determination; however, in

two other medical listings, we use genetic test results as part of the

criteria to evaluate whether a person's impairment meets the listing. [10] Additional evidence, including signs and symptoms of a person's

impairment, is generally necessary to make a disability determination.

As genetic testing continues to advance, we will consider appropriate

changes to our program policy.

Will we purchase genetic testing

by way of consultative examination (CE)?

No. We will not order genetic testing in a CE. While genetic test

results may provide valuable information when they appear as part of a

large body of MER, they are not necessary to establish a finding of

disability.

Do we consider medical evidence that

includes the results of genetic tests?

to our program policy.

Will we purchase genetic testing

by way of consultative examination (CE)?

No. We will not order genetic testing in a CE. While genetic test

results may provide valuable information when they appear as part of a

large body of MER, they are not necessary to establish a finding of

disability.

Do we consider medical evidence that

includes the results of genetic tests?

Yes, we consider all evidence we receive, including genetic test

results, when evaluating a disability claim. [11] In considering a

disability claim, we generally request evidence about a person's medical

impairment(s) for a period of at least the 12 months (and a longer

duration if circumstances warrant) preceding the month in which a person

files an application. [12] This includes objective medical evidence, a

claimant's reported symptoms, statements from others about the effects

of the claimant's impairment(s), and opinion evidence. [13]

The results of genetic tests constitute laboratory findings, which

are considered objective medical evidence. Consistent with our

regulations, when genetic test results are available, we will consider

them, together with all relevant evidence available in the case record,

such as signs, symptoms, other laboratory findings, and medical opinion

evidence. [14] When evidence is inconsistent, such as when genetic test

results are inconsistent with other substantial evidence, we will

resolve the inconsistency when it is material to the disability

determination, as we do with all medical evidence. [15]

Do we require genetic test results

to find a claimant disabled?

such as signs, symptoms, other laboratory findings, and medical opinion

evidence. [14] When evidence is inconsistent, such as when genetic test

results are inconsistent with other substantial evidence, we will

resolve the inconsistency when it is material to the disability

determination, as we do with all medical evidence. [15]

Do we require genetic test results

to find a claimant disabled?

No, genetic test results are not required for a finding of

disability. A finding of disability requires a claimant to have an MDI,

which can be expected to result in death or which has lasted or can be

expected to last for a continuing period of not less than 12 months. [16] We

establish physical and mental impairments by medical evidence consisting

of signs, symptoms, and laboratory findings. [17] While several medical

listings require or reference the use of genetic test results as a way

to meet the applicable listing at step 3 of the sequential evaluation

process, [18] our rules do not require the results of genetic tests in order

to determine that a person is disabled.

Who typically provides genetic test

evidence?

We typically receive the results of genetic tests in medical evidence

from clinical geneticists, other physicians, and genetic counselors.

Claimants sometimes provide results of “direct-to-consumer”

(DTC) medical tests. We will consider genetic test results from all

sources, medical and otherwise. [19]

r

to determine that a person is disabled.

Who typically provides genetic test

evidence?

We typically receive the results of genetic tests in medical evidence

from clinical geneticists, other physicians, and genetic counselors.

Claimants sometimes provide results of “direct-to-consumer”

(DTC) medical tests. We will consider genetic test results from all

sources, medical and otherwise. [19]

- Geneticists and other physicians Clinical geneticists are physicians specializing in the diagnosis

and management of hereditary disorders. Clinical geneticists and other

licensed physicians have a medical degree and are acceptable medical

sources (AMS). We establish the existence of an MDI using objective

medical evidence (signs or laboratory results) from an AMS.

Cytogeneticists, biochemical geneticists, and molecular geneticists may

hold a Ph.D. or a medical degree (e.g., M.D. or D.O.); those without a

medical degree are generally not AMSs. For example, Ph.D.

cytogeneticists typically work in laboratories or act as clinical

consultants, but do not regularly interact with patients. These types

of geneticists may be involved in obtaining genetic testing results and

may be board-certified, but they are not AMSs if they are not also

licensed physicians or otherwise classified as an AMS.

- Genetic counselors Genetic counselors assess and communicate genetic risk for medical

conditions in a person and members of his or her biological family.

They obtain and evaluate personal and family medical histories as well

as identify and coordinate genetic tests and other diagnostic studies,

as appropriate, to obtain needed information for a genetic assessment.

They are also able to explain the clinical implications of genetic

laboratory tests and other diagnostic studies and their results

person and members of his or her biological family.

They obtain and evaluate personal and family medical histories as well

as identify and coordinate genetic tests and other diagnostic studies,

as appropriate, to obtain needed information for a genetic assessment.

They are also able to explain the clinical implications of genetic

laboratory tests and other diagnostic studies and their results. [20] These professionals typically hold a master's degree in Genetic

Counseling and may be board-certified by the American Board of Genetic

Counseling (denoted by the use of the credential “Certified

Genetic Counselor” or CGC). However, we do not consider a genetic

counselor to be an AMS under our rules unless the individual is also a

licensed physician or other AMS provider. This is true even when the

genetic counselor is licensed to practice genetic counseling by his or

her State. We cannot establish the existence of an MDI based solely on

a report from a genetic counselor. We can use evidence from genetic

counselors working in an independent capacity to show the severity of a

person's impairment and how it affects the person's ability to work, or,

for children, how the child typically functions compared to children of

the same age who do not have impairments. [21]

- “Direct-to-consumer” (DTC) tests DTC genetic tests are available and appear to be growing in

popularity. These tests are generally marketed directly to consumers

via television, print advertisements, or the internet. A person

typically collects a DNA sample at home, such as by swabbing the inside

of the cheek, and mails the sample back to the laboratory for testing.

In some cases, the person must visit a health clinic to have blood

drawn. The samples are analyzed and consumers are directly notified of

the results by mail, over the telephone, or online. [22] There is currently little regulation and oversight of DTC genetic

testing, leading to concerns about its accuracy, reliability, and

clinical relevance

ls the sample back to the laboratory for testing.

In some cases, the person must visit a health clinic to have blood

drawn. The samples are analyzed and consumers are directly notified of

the results by mail, over the telephone, or online. [22] There is currently little regulation and oversight of DTC genetic

testing, leading to concerns about its accuracy, reliability, and

clinical relevance. [23] DTC services generally do not establish an

appropriate chain of custody of the DNA sample. There is no assurance

that DTC genetic test results belong to a given claimant, as the entire

transaction typically takes place with no personal interaction with a

medical source or without any type of oversight that confirms the

identity of the person providing the sample. For these reasons, DTC

genetic test results cannot be the basis for establishing an MDI,

regardless of AMS adoption or involvement. [24] Nevertheless, DTC results,

when consistent with independent credible objective medical evidence,

can help corroborate other findings or the claimant's allegations. [25]

Geneticists and other physicians

Clinical geneticists are physicians specializing in the diagnosis

and management of hereditary disorders. Clinical geneticists and other

licensed physicians have a medical degree and are acceptable medical

sources (AMS). We establish the existence of an MDI using objective

medical evidence (signs or laboratory results) from an AMS.

Cytogeneticists, biochemical geneticists, and molecular geneticists may

hold a Ph.D. or a medical degree (e.g., M.D. or D.O.); those without a

medical degree are generally not AMSs. For example, Ph.D.

cytogeneticists typically work in laboratories or act as clinical

consultants, but do not regularly interact with patients. These types

of geneticists may be involved in obtaining genetic testing results and

may be board-certified, but they are not AMSs if they are not also

licensed physicians or otherwise classified as an AMS.

Genetic counselors

ee are generally not AMSs. For example, Ph.D.

cytogeneticists typically work in laboratories or act as clinical

consultants, but do not regularly interact with patients. These types

of geneticists may be involved in obtaining genetic testing results and

may be board-certified, but they are not AMSs if they are not also

licensed physicians or otherwise classified as an AMS.

Genetic counselors

Genetic counselors assess and communicate genetic risk for medical

conditions in a person and members of his or her biological family.

They obtain and evaluate personal and family medical histories as well

as identify and coordinate genetic tests and other diagnostic studies,

as appropriate, to obtain needed information for a genetic assessment.

They are also able to explain the clinical implications of genetic

laboratory tests and other diagnostic studies and their results. [20]

These professionals typically hold a master's degree in Genetic

Counseling and may be board-certified by the American Board of Genetic

Counseling (denoted by the use of the credential “Certified

Genetic Counselor” or CGC). However, we do not consider a genetic

counselor to be an AMS under our rules unless the individual is also a

licensed physician or other AMS provider. This is true even when the

genetic counselor is licensed to practice genetic counseling by his or

her State. We cannot establish the existence of an MDI based solely on

a report from a genetic counselor. We can use evidence from genetic

counselors working in an independent capacity to show the severity of a

person's impairment and how it affects the person's ability to work, or,

for children, how the child typically functions compared to children of

the same age who do not have impairments. [21]

“Direct-to-consumer” (DTC) tests

nce of an MDI based solely on

a report from a genetic counselor. We can use evidence from genetic

counselors working in an independent capacity to show the severity of a

person's impairment and how it affects the person's ability to work, or,

for children, how the child typically functions compared to children of

the same age who do not have impairments. [21]

“Direct-to-consumer” (DTC) tests

DTC genetic tests are available and appear to be growing in

popularity. These tests are generally marketed directly to consumers

via television, print advertisements, or the internet. A person

typically collects a DNA sample at home, such as by swabbing the inside

of the cheek, and mails the sample back to the laboratory for testing.

In some cases, the person must visit a health clinic to have blood

drawn. The samples are analyzed and consumers are directly notified of

the results by mail, over the telephone, or online. [22]

There is currently little regulation and oversight of DTC genetic

testing, leading to concerns about its accuracy, reliability, and

clinical relevance. [23] DTC services generally do not establish an

appropriate chain of custody of the DNA sample. There is no assurance

that DTC genetic test results belong to a given claimant, as the entire

transaction typically takes place with no personal interaction with a

medical source or without any type of oversight that confirms the

identity of the person providing the sample. For these reasons, DTC

genetic test results cannot be the basis for establishing an MDI,

regardless of AMS adoption or involvement. [24] Nevertheless, DTC results,

when consistent with independent credible objective medical evidence,

can help corroborate other findings or the claimant's allegations. [25]

Can we consider genetic test

results in the sequential evaluation process?

the sample. For these reasons, DTC

genetic test results cannot be the basis for establishing an MDI,

regardless of AMS adoption or involvement. [24] Nevertheless, DTC results,

when consistent with independent credible objective medical evidence,

can help corroborate other findings or the claimant's allegations. [25]

Can we consider genetic test

results in the sequential evaluation process?

Yes, we consider genetic test results and all other evidence in

varying ways throughout the sequential evaluation process. [26] At step 2 we

establish whether a person has an MDI and whether the impairment or

combination of impairments is severe, i.e., whether it significantly

limits the physical or mental ability to do basic work activities. [27] Information from genetic test results can help establish an MDI if they

are from an AMS and not based on DTC test results. However, a genetic

test alone cannot typically show whether or not an impairment is severe.

At step 3 we consider whether the impairment meets or medically equals

the requirements of a listed impairment in the medical listings.

Several of our medical listings include criteria that require

appropriate genetic test results for an impairment to meet the listing. [28]

If a person's MDI does not meet or medically equal a listing, we

assess whether the impairment(s) results in functional limitations that

would prevent him or her from performing past relevant work or other

work at steps 4 and 5 of sequential evaluation. [29] For children, we assess

whether the impairment(s) causes marked and severe functional

limitations. [30] Genetic test results generally do not provide us with

significant information about impairment severity or functional

capacities.

results in functional limitations that

would prevent him or her from performing past relevant work or other

work at steps 4 and 5 of sequential evaluation. [29] For children, we assess

whether the impairment(s) causes marked and severe functional

limitations. [30] Genetic test results generally do not provide us with

significant information about impairment severity or functional

capacities.

- Can we use genetic test results to establish an MDI (Step 2)? When genetic test results come from an AMS and are not based on DTC

genetic testing, we can use the evidence to establish an MDI if there

are signs and symptoms consistent with the impairment. [31] We can consider

the results of previously-performed genetic testing in establishing an

MDI, if signs and symptoms of an impairment are present. We cannot use

the results of genetic tests, in the absence of any signs or symptoms,

as the sole basis for establishing an MDI, even if the results are

highly- suggestive of the eventual development of an impairment. [32] We

must be able to establish that a person has an MDI at the disability

onset date. Although non-physician geneticists are generally not AMSs, a

physician or other AMS typically reviews or evaluates test results

produced by a non-physician geneticist and incorporates these test

results into an individual's medical record. In such a case, the

evidence can be used to help establish an MDI. Similarly, genetic

counselors are generally not AMSs. Therefore, we cannot establish the

existence of an MDI based solely on a report from a genetic counselor.

However, genetic counselors typically work in a setting where they are

in close collaboration with a physician or other AMS. When a person is

referred for diagnostic testing by a genetic counselor, the results are

often reviewed, evaluated, interpreted, or used by a physician and

incorporated into a medical record. In such a case, this evidence can

help establish an MDI

a genetic counselor.

However, genetic counselors typically work in a setting where they are

in close collaboration with a physician or other AMS. When a person is

referred for diagnostic testing by a genetic counselor, the results are

often reviewed, evaluated, interpreted, or used by a physician and

incorporated into a medical record. In such a case, this evidence can

help establish an MDI. Similar to imaging from an x-ray or MRI, which requires AMS

involvement to establish an MDI, a genetic test result without AMS

involvement cannot establish an MDI. A DTC genetic test result, even if

evaluated, interpreted, or otherwise utilized by an AMS, cannot lead to

the establishment of an MDI because there is no assurance that the test

results belong to a given claimant and no appropriate chain of custody

of the sample is established. Many disorders with a known genetic basis can be, and often are,

established by means other than genetic tests. For example, although

diagnostic genetic tests for cystic fibrosis exist, as do guidelines

surrounding their use, the most common confirmatory test for this

disease is the sweat chloride test, which measures the concentrations of

a certain electrolyte in a person's sweat. [33] It is not a genetic test.

While we consider genetic test results in conjunction with the rest of

the objective medical evidence when they are available, we do not

require a person to undergo such testing to prove they have an MDI or

are disabled.

confirmatory test for this

disease is the sweat chloride test, which measures the concentrations of

a certain electrolyte in a person's sweat. [33] It is not a genetic test.

While we consider genetic test results in conjunction with the rest of

the objective medical evidence when they are available, we do not

require a person to undergo such testing to prove they have an MDI or

are disabled.

- Can we evaluate impairment severity using the results of genetic

tests (Step 2)? To some extent, genetic test results can be helpful in our overall

impairment evaluation, but generally they do not help us determine

whether or not an impairment is severe. For an impairment to be severe,

it must significantly limit an adult's physical or mental ability to do

basic work activities. [34] In the case of a child, for an impairment to be

severe it must be more than a slight abnormality that causes more than

minimal functional limitations. [35] Genetic test results generally do not provide information about the

degree of functional limitation associated with an impairment, but they

can be used to help evaluate for consistency with or supportability of

alleged symptoms and limitations. With the exception of non-mosaic Down

Syndrome, we need evidence other than genetic test results to show a

person's impairment is severe. This evidence comes from other medical

records, a claimant's report of symptoms, and statements from nonmedical

sources. [36]

h an impairment, but they

can be used to help evaluate for consistency with or supportability of

alleged symptoms and limitations. With the exception of non-mosaic Down

Syndrome, we need evidence other than genetic test results to show a

person's impairment is severe. This evidence comes from other medical

records, a claimant's report of symptoms, and statements from nonmedical

sources. [36]

- Can we evaluate medical listings with genetic test results (Step

3)? For several medical listings, we use genetic test results to evaluate

whether a person's impairment meets a medical listing. Four of our

medical listings include, as part of the criteria for an impairment to

meet a listing, the use of appropriate genetic test results. [37] Listings

10.06 and 110.06 for non-mosaic Down syndrome (trisomy 21) use the

results of genetic tests. Karyotyping for Down syndrome is the

“gold standard” for diagnosis. We typically require the

results of karyotype analysis for an impairment to meet 10.06A, 10.06B,

110.06A, or 110.06B. [38] Additionally, we require diagnostic genetic test

results for xeroderma pigmentosum to meet listing 8.07A or 108.07A. We may also use genetic test results indicating the presence of a

catastrophic congenital disorder, such as Edward's syndrome (trisomy

18), to find a child's impairment meets listing 110.08. Other medical

listings are for disorders, such as cystic fibrosis [39] and chronic

myelogenous leukemia, with at least one known genetic basis and an

available associated test. [40] Often, additional medical evidence is

required to find a person's impairment meets a relevant listing. [41]

ital disorder, such as Edward's syndrome (trisomy

18), to find a child's impairment meets listing 110.08. Other medical

listings are for disorders, such as cystic fibrosis [39] and chronic

myelogenous leukemia, with at least one known genetic basis and an

available associated test. [40] Often, additional medical evidence is

required to find a person's impairment meets a relevant listing. [41]

- Can we evaluate the degree of limitation and residual functional

capacity (RFC) using genetic test results (Steps 4 and 5)? While genetic tests may help to establish the presence of a disorder

and assist in determining whether an impairment meets or medically

equals a listing, the results alone generally do not provide us with

information about the degree of a person's limitation due to the

impairment. A claimant's RFC reflects the most he or she can do despite

his or her limitations. [42] If an adult's impairment does not meet or

medically equal a listing at step 3 of the sequential evaluation

process, we assess RFC, which applies to both steps 4 and 5. If a

child's impairment does not meet or medically equal a listing, we assess

functional equivalence. Functional equivalence deals with broad areas

of functioning intended to capture all of what a child can or cannot

do. [43] As is the case with RFC, genetic test results alone generally do not

provide us with information about the degree of limitation as it relates

to functional equivalence. To assess a claimant's impairments beyond step 3, we need non-genetic

evidence about the impairment's effect on a person's functioning to

determine the most the person can do despite his or her limitations and

restrictions. [44] Many disorders associated with known gene mutations are

multifactorial in nature. Environmental and other influences that are

not well-understood affect the development of medical signs and symptoms

resulting from the disorder and the degree of limitation a person with

the disorder experiences

oning to

determine the most the person can do despite his or her limitations and

restrictions. [44] Many disorders associated with known gene mutations are

multifactorial in nature. Environmental and other influences that are

not well-understood affect the development of medical signs and symptoms

resulting from the disorder and the degree of limitation a person with

the disorder experiences. Therefore, additional evidence is necessary

to adequately assess a person's RFC and ability to engage in work

activities. However, results of genetic tests can be assessed for consistency

with a person's symptoms and alleged limitations. For example, genetic

test results may lead an AMS to diagnose familial Mediterranean fever.

A common symptom is painful inflammation in various areas of the body,

including joints. [45] If someone complains of significant joint pain

and has genetic test results leading to a diagnosis of familial

Mediterranean fever, we can take into account that the claimant's

reported symptoms are consistent with the genetic test results.

Can we use genetic test results to establish an MDI (Step 2)?

When genetic test results come from an AMS and are not based on DTC

genetic testing, we can use the evidence to establish an MDI if there

are signs and symptoms consistent with the impairment. [31] We can consider

the results of previously-performed genetic testing in establishing an

MDI, if signs and symptoms of an impairment are present. We cannot use

the results of genetic tests, in the absence of any signs or symptoms,

as the sole basis for establishing an MDI, even if the results are

highly- suggestive of the eventual development of an impairment. [32] We

must be able to establish that a person has an MDI at the disability

onset date.

etic testing in establishing an

MDI, if signs and symptoms of an impairment are present. We cannot use

the results of genetic tests, in the absence of any signs or symptoms,

as the sole basis for establishing an MDI, even if the results are

highly- suggestive of the eventual development of an impairment. [32] We

must be able to establish that a person has an MDI at the disability

onset date.

Although non-physician geneticists are generally not AMSs, a

physician or other AMS typically reviews or evaluates test results

produced by a non-physician geneticist and incorporates these test

results into an individual's medical record. In such a case, the

evidence can be used to help establish an MDI. Similarly, genetic

counselors are generally not AMSs. Therefore, we cannot establish the

existence of an MDI based solely on a report from a genetic counselor.

However, genetic counselors typically work in a setting where they are

in close collaboration with a physician or other AMS. When a person is

referred for diagnostic testing by a genetic counselor, the results are

often reviewed, evaluated, interpreted, or used by a physician and

incorporated into a medical record. In such a case, this evidence can

help establish an MDI.

Similar to imaging from an x-ray or MRI, which requires AMS

involvement to establish an MDI, a genetic test result without AMS

involvement cannot establish an MDI. A DTC genetic test result, even if

evaluated, interpreted, or otherwise utilized by an AMS, cannot lead to

the establishment of an MDI because there is no assurance that the test

results belong to a given claimant and no appropriate chain of custody

of the sample is established.

quires AMS

involvement to establish an MDI, a genetic test result without AMS

involvement cannot establish an MDI. A DTC genetic test result, even if

evaluated, interpreted, or otherwise utilized by an AMS, cannot lead to

the establishment of an MDI because there is no assurance that the test

results belong to a given claimant and no appropriate chain of custody

of the sample is established.

Many disorders with a known genetic basis can be, and often are,

established by means other than genetic tests. For example, although

diagnostic genetic tests for cystic fibrosis exist, as do guidelines

surrounding their use, the most common confirmatory test for this

disease is the sweat chloride test, which measures the concentrations of

a certain electrolyte in a person's sweat. [33] It is not a genetic test.

While we consider genetic test results in conjunction with the rest of

the objective medical evidence when they are available, we do not

require a person to undergo such testing to prove they have an MDI or

are disabled.

Can we evaluate impairment severity using the results of genetic

tests (Step 2)?

To some extent, genetic test results can be helpful in our overall

impairment evaluation, but generally they do not help us determine

whether or not an impairment is severe. For an impairment to be severe,

it must significantly limit an adult's physical or mental ability to do

basic work activities. [34] In the case of a child, for an impairment to be

severe it must be more than a slight abnormality that causes more than

minimal functional limitations. [35]

impairment evaluation, but generally they do not help us determine

whether or not an impairment is severe. For an impairment to be severe,

it must significantly limit an adult's physical or mental ability to do

basic work activities. [34] In the case of a child, for an impairment to be

severe it must be more than a slight abnormality that causes more than

minimal functional limitations. [35]

Genetic test results generally do not provide information about the

degree of functional limitation associated with an impairment, but they

can be used to help evaluate for consistency with or supportability of

alleged symptoms and limitations. With the exception of non-mosaic Down

Syndrome, we need evidence other than genetic test results to show a

person's impairment is severe. This evidence comes from other medical

records, a claimant's report of symptoms, and statements from nonmedical

sources. [36]

Can we evaluate medical listings with genetic test results (Step

3)?

For several medical listings, we use genetic test results to evaluate

whether a person's impairment meets a medical listing. Four of our

medical listings include, as part of the criteria for an impairment to

meet a listing, the use of appropriate genetic test results. [37] Listings

10.06 and 110.06 for non-mosaic Down syndrome (trisomy 21) use the

results of genetic tests. Karyotyping for Down syndrome is the

“gold standard” for diagnosis. We typically require the

results of karyotype analysis for an impairment to meet 10.06A, 10.06B,

110.06A, or 110.06B. [38] Additionally, we require diagnostic genetic test

results for xeroderma pigmentosum to meet listing 8.07A or 108.07A.

and 110.06 for non-mosaic Down syndrome (trisomy 21) use the

results of genetic tests. Karyotyping for Down syndrome is the

“gold standard” for diagnosis. We typically require the

results of karyotype analysis for an impairment to meet 10.06A, 10.06B,

110.06A, or 110.06B. [38] Additionally, we require diagnostic genetic test

results for xeroderma pigmentosum to meet listing 8.07A or 108.07A.

We may also use genetic test results indicating the presence of a

catastrophic congenital disorder, such as Edward's syndrome (trisomy

18), to find a child's impairment meets listing 110.08. Other medical

listings are for disorders, such as cystic fibrosis [39] and chronic

myelogenous leukemia, with at least one known genetic basis and an

available associated test. [40] Often, additional medical evidence is

required to find a person's impairment meets a relevant listing. [41]

Can we evaluate the degree of limitation and residual functional

capacity (RFC) using genetic test results (Steps 4 and 5)?

While genetic tests may help to establish the presence of a disorder

and assist in determining whether an impairment meets or medically

equals a listing, the results alone generally do not provide us with

information about the degree of a person's limitation due to the

impairment. A claimant's RFC reflects the most he or she can do despite

his or her limitations. [42] If an adult's impairment does not meet or

medically equal a listing at step 3 of the sequential evaluation

process, we assess RFC, which applies to both steps 4 and 5. If a

child's impairment does not meet or medically equal a listing, we assess

functional equivalence. Functional equivalence deals with broad areas

of functioning intended to capture all of what a child can or cannot

do. [43] As is the case with RFC, genetic test results alone generally do not

provide us with information about the degree of limitation as it relates

to functional equivalence.

f a

child's impairment does not meet or medically equal a listing, we assess

functional equivalence. Functional equivalence deals with broad areas

of functioning intended to capture all of what a child can or cannot

do. [43] As is the case with RFC, genetic test results alone generally do not

provide us with information about the degree of limitation as it relates

to functional equivalence.

To assess a claimant's impairments beyond step 3, we need non-genetic

evidence about the impairment's effect on a person's functioning to

determine the most the person can do despite his or her limitations and

restrictions. [44] Many disorders associated with known gene mutations are

multifactorial in nature. Environmental and other influences that are

not well-understood affect the development of medical signs and symptoms

resulting from the disorder and the degree of limitation a person with

the disorder experiences. Therefore, additional evidence is necessary

to adequately assess a person's RFC and ability to engage in work

activities.

However, results of genetic tests can be assessed for consistency

with a person's symptoms and alleged limitations. For example, genetic

test results may lead an AMS to diagnose familial Mediterranean fever.

A common symptom is painful inflammation in various areas of the body,

including joints. [45] If someone complains of significant joint pain

and has genetic test results leading to a diagnosis of familial

Mediterranean fever, we can take into account that the claimant's

reported symptoms are consistent with the genetic test results.

If a person is found disabled,

can we use genetic test results

when setting a diary for continuing disability review (CDR)?

dy,

including joints. [45] If someone complains of significant joint pain

and has genetic test results leading to a diagnosis of familial

Mediterranean fever, we can take into account that the claimant's

reported symptoms are consistent with the genetic test results.

If a person is found disabled,

can we use genetic test results

when setting a diary for continuing disability review (CDR)?

Yes. We consider all impairments and case facts to determine when to

conduct a CDR. We conduct a full evaluation of all evidence, including

genetic test results, when setting diary dates. Due to the diversity of

types of genetic tests and the differing types of information that

genetic test results can provide, the impact of genetic test results on

diary lengths will vary.

What is our policy regarding the

disclosure of the results of genetic tests?

The Privacy Act of 1974 (5 U.S.C. 552a), section 1106 of the Social

Security Act (42 U.S.C. 1306), and our disclosure regulations ( 20 CFR Part

401 ) govern the collection, maintenance, and use of an individual's

information in our systems of records. Although these authorities do

not specifically address requirements for the disclosure of genetic test

results, they apply to the extent we maintain this type of information

in our records.

Under the Privacy Act and our disclosure regulations, we generally

cannot disclose genetic test results without the consent of the subject

of the record. For example, if an individual's MER contains genetic

test results and he or she authorizes us to disclose this specific

information to a third party, we will do so with a valid, written

consent that meets our regulatory requirements.

cords.

Under the Privacy Act and our disclosure regulations, we generally

cannot disclose genetic test results without the consent of the subject

of the record. For example, if an individual's MER contains genetic

test results and he or she authorizes us to disclose this specific

information to a third party, we will do so with a valid, written

consent that meets our regulatory requirements.

In addition, the Privacy Act grants individuals a right of access to

any records we maintain about them in our systems of records.

Therefore, any genetic test results we maintain in an individual's MER

(including records a medical consultative examiner may have generated on

our behalf) are subject to these access requirements, as is the case

with all medical evidence. However, if we determine that direct access

to the medical information is likely to have an adverse effect on the

subject of the record, we will follow certain procedures in providing

access to the information. [46]

EFFECTIVE DATE: This SSR is effective on April 13, 2016.

CROSS REFERENCES: SSR 86-8 ,

Titles II and XVI: The Sequential Evaluation Process; SSR 96-2p , Titles II

and XVI: Giving Controlling Weight to Treating Source Medical Opinions; SSR 96-5p , Titles II

and XVI: Medical Source Opinions on Issues Reserved to the Commissioner; SSR 16-3p ,

Titles II and XVI: Evaluation of Symptoms in Disability Claims; [*] SSR 96-8p , Titles II

and XVI: Assessing Residual Functional Capacity in Initial Claims; SSR 06-3p ,

Titles II and XVI: Considering Opinions and Other Evidence from Sources

Who Are Not “Acceptable Medical Sources” in Disability

Claims; Considering Decisions on Disability by Other Governmental and

Nongovernmental Agencies;

and Program Operations Manual System (POMS)

DI 00115.015, DI 22501.001, DI 22505.001, DI 22505.003, DI 24501.020,

DI 24515.001, DI 24515.061, DI 24515.062, DI 25201.005.

es II and XVI: Considering Opinions and Other Evidence from Sources

Who Are Not “Acceptable Medical Sources” in Disability

Claims; Considering Decisions on Disability by Other Governmental and

Nongovernmental Agencies;

and Program Operations Manual System (POMS)

DI 00115.015, DI 22501.001, DI 22505.001, DI 22505.003, DI 24501.020,

DI 24515.001, DI 24515.061, DI 24515.062, DI 25201.005.

[1] For simplicity, we refer in this SSR only to initial claims for disability

benefits under titles II and XVI of the Social Security Act (Act).

However, the policy interpretations in this SSR also apply to continuing

disability reviews of adults and children under sections 223(f) and 1614(a)(4) of the Act, and to redeterminations of eligibility for

benefits we make in accordance with section 1614(a)(3)(H) of the Act when a child who is receiving title XVI payments based on

disability attains age 18.

[2] For help

with the definitions of the terms and concepts related to genetic

testing in this SSR, see the National Human Genome Research Institute

(NHGRI) Talking Glossary of Genetic Terms, available at http://www.genome.gov/glossary/index.cfm .

[3] Clinicians may perform gene expression profiling for certain types of

malignant tumors to gather information for cancer treatment. We do not

consider such tests in this SSR.

[4] See the Genetics Home Reference page for hemochromatosis available at http://ghr.nlm.nih.gov/condition/hemochromatosis .

[5] See the

National Cancer Institute, at the National Institutes of Health's,

discussion of BRCA1 and BRCA2 , available at http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/HealthProfessional/page2 .

[6] We do

not make a determination of disability for fetuses. We can, however,

consider the results of certain prenatal genetic tests as part of the

MER in accordance with our policy once the child is born and a

disability claim has been filed on his or her behalf.

n of BRCA1 and BRCA2 , available at http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/HealthProfessional/page2 .

[6] We do

not make a determination of disability for fetuses. We can, however,

consider the results of certain prenatal genetic tests as part of the

MER in accordance with our policy once the child is born and a

disability claim has been filed on his or her behalf.

[7] Current

statistics on genetic variants and corresponding conditions can be found

at the Online Mendelian Inheritance in Man database on the

“Statistics” page, available at http://www.ncbi.nlm.nih.gov/clinvar/submitters/ or http://www.omim.org/statistics/entry .

[8] See the

NCBI Genetic Testing Registry, available at http://www.ncbi.nlm.nih.gov/gtr/all/tests/?term=all%5bsb (last

visited August 2015). See also, the American Medical Association (AMA)

page regarding genetic testing, available at http://www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-medicine/related-policy-topics/genetic-testing.page ? See

also, the Centers for Disease Control and Prevention (CDC) page

regarding genetic testing, available at http://www.cdc.gov/genomics/gtesting/ .

[9] Under

listings 10.06A and 110.06A, a laboratory report of karyotype analysis

not signed by a physician is also sufficient if it is accompanied by a

statement of a physician that the person has Down syndrome.

[10] These

listings are for xeroderma pigmentosum (8.07A and 108.07A), 20 CFR part 404,

subpart P, appendix 1 .

[11] 20 CFR

404.1512(b)(1) , 404.1513(b)(3) , 404.1520(a)(3) , 404.1528(c) , 416.912(b)(1) , 416.913(b)(3) , 416.920(a)(3) , 416.928(c) .

[12] 20 CFR

404.1512(d) , 404.1519m , 416.912(d) , and 416.919m .

[13] 20 CFR

404.1512(b) , 404.1513(d) , 404.1527 , 416.912(b) , 416.913(d) , and 416.927 . SSR 06-03p.

[14] 20 CFR

404.1512(b) , 404.1520(a)(3) , 416.912(b) , 416.920(a)(3) , 416.924(a) , and 416.924a(a)(1)(i) .

[15] 20 CFR 404.1520b and 416.920b

[16] 20 CFR 404.1505(a) and 416.905(a) .

)(3) , 416.920(a)(3) , 416.928(c) .

[12] 20 CFR

404.1512(d) , 404.1519m , 416.912(d) , and 416.919m .

[13] 20 CFR

404.1512(b) , 404.1513(d) , 404.1527 , 416.912(b) , 416.913(d) , and 416.927 . SSR 06-03p.

[14] 20 CFR

404.1512(b) , 404.1520(a)(3) , 416.912(b) , 416.920(a)(3) , 416.924(a) , and 416.924a(a)(1)(i) .

[15] 20 CFR 404.1520b and 416.920b

[16] 20 CFR 404.1505(a) and 416.905(a) .

[17] 20 CFR 404.1508 and 416.908 .

[18] Listings 8.07, 10.06A, 10.06B, 108.07, 110.06A, and 110.06B, 20 CFR part 404,

subpart P, appendix 1 , require genetic testing results in order for

these impairments (genetic photosensitivity disorders and non-mosaic

Down syndrome) to meet the listing.

[19] 20 CFR 404.1513(a) , 404.1513(d) , 416.913(a) , and 416.913(d)

[20] See the National Society of Genetic Counselors (NSGC) page regarding genetic

counselor licensure, available at http://nsgc.org/p/cm/ld/fid=18 .

[21] 20 CFR

404.1513(d) and 416.913(d) .

[22] See the Genetics Home Reference page, a service of the U.S. National Library

of Medicine, detailing what direct-to-consumer genetic testing is,

available at http://ghr.nlm.nih.gov/handbook/testing/directtoconsumer . See

also, the American College of Preventative Medicine's Genetic Testing

Clinical Reference for Clinicians and Genetic Testing Time tool pages,

illustrating the growth of genetic testing, available at http://www.acpm.org/?GeneticTestgClinRef .

[23] See Yale

Journal of Biology and Medicine, Direct-to-Consumer Genetic Testing: A

Comprehensive View. (Yale J Biol Med. Sep 2013; 86(3): 359-365). See

also, the American Society of Human Genetics statement on

direct-to-consumer genetic testing in the United States. (Am. J. Hum.

Genet. 2007; 81: 635-637).

[24] 20 CFR 404.1508 and 416.908 .

[25] 20 CFR 404.1520b and 416.920b .

[26] Step 1 of the sequential evaluation process considers work activity and whether

a claimant is engaged in substantial gainful activity. Genetic testing

or genetic test results do not impact this step.

netics statement on

direct-to-consumer genetic testing in the United States. (Am. J. Hum.

Genet. 2007; 81: 635-637).

[24] 20 CFR 404.1508 and 416.908 .

[25] 20 CFR 404.1520b and 416.920b .

[26] Step 1 of the sequential evaluation process considers work activity and whether

a claimant is engaged in substantial gainful activity. Genetic testing

or genetic test results do not impact this step.

[27] For

children, we will consider whether you have more than a slight

abnormality or combination of slight abnormalities that cause more than

minimal functional limitations. See 20 CFR 404.1520(c) , 416.920(c) , and 416.924(c) .

[28] See FN 18 .

[29] 20 CFR 404.1520(f) , 404.1520(g) , 416.920(f) , and 416.920(g) .

[30] 20 CFR 416.906 and 416.926a .

[31] Predictive, as opposed to diagnostic, test results from an AMS do not

constitute laboratory results that can establish an MDI.

[32] For

example, see FN5 regarding the predictive nature of genetic tests for BRCA1 and BRCA2 . The meeting of listings 10.06 or 110.06,

based on a karyotype report signed by a physician, would be an

exception.

[33] See http://www.nlm.nih.gov/medlineplus/ency/article/003630.htm .

[34] 20 CFR 404.1520(c) and 416.920(c) .

[35] 20 CFR

416.924(c) .

[36] In cases

of a catastrophic congenital disorder, as detailed in listing 110.08, 20 CFR part 404,

subpart P, appendix 1 , or other extreme cases, genetic

test results alone may show a person's impairment is severe.

[37] These

listings include those for xeroderma pigmentosum (8.07A and 108.07A) and

non-mosaic Down syndrome (10.06A and 110.06A), 20 CFR part 404,

subpart P, appendix 1 .

[36] In cases

of a catastrophic congenital disorder, as detailed in listing 110.08, 20 CFR part 404,

subpart P, appendix 1 , or other extreme cases, genetic

test results alone may show a person's impairment is severe.

[37] These

listings include those for xeroderma pigmentosum (8.07A and 108.07A) and

non-mosaic Down syndrome (10.06A and 110.06A), 20 CFR part 404,

subpart P, appendix 1 .

[38] Listings 10.06 and 110.06, 20 CFR part 404,

subpart P, appendix 1 , require that a

claimant's non-mosaic Down syndrome be documented by: A. a laboratory

report of karyotype analysis signed by a physician, or both a laboratory

report of karyotype analysis not signed by a physician and a statement

by a physician that you have Down syndrome (see 10.00C1); B. a

physician's report stating that you have chromosome 21 trisomy or

chromosome 21 translocation consistent with prior karyotype analysis

with the distinctive facial or other physical features of Down syndrome

(see 10.00C2a); or C. a physician's report stating that you have Down

syndrome with the distinctive facial or other physical features and

evidence demonstrating that you function at a level consistent with

non-mosaic Down syndrome (see 10.00C2b).

[39] Listings 3.04 and 103.04, 20 CFR part 404,

subpart P, appendix 1 .

[40] Listings 13.06B and 113.06B, 20 CFR part 404,

subpart P, appendix 1 .

[41] 20 CFR part 404,

subpart P, appendix 1 . For example, Marfan syndrome (listings

4.00H and 104.00F) and genetic photosensitivity disorders other than

xeroderma pigmentosum (listing 8.07 and 108.07).

[42] 20 CFR 404.1545 and 416.945 .

[43] 20 CFR 416.906 and 416.926a .

[44] 20 CFR 404.1545(a) , 416.945(a) , and SSR 96-8p , Titles II and

XVI: Assessing Residual Functional Capacity in Initial Claims (1996),

61 FR 34474, available at http://www.socialsecurity.gov/OP_Home/rulings/di/01/SSR96-08-di-01.html .

tosensitivity disorders other than

xeroderma pigmentosum (listing 8.07 and 108.07).

[42] 20 CFR 404.1545 and 416.945 .

[43] 20 CFR 416.906 and 416.926a .

[44] 20 CFR 404.1545(a) , 416.945(a) , and SSR 96-8p , Titles II and

XVI: Assessing Residual Functional Capacity in Initial Claims (1996),

61 FR 34474, available at http://www.socialsecurity.gov/OP_Home/rulings/di/01/SSR96-08-di-01.html .

[45] See http://ghr.nlm.nih.gov/condition/familial-mediterranean-fever . [46] 20 CFR 401.55 . [*] Federal Register Vol. 81,

No. 77, page 23543 removed reference "SSR 96-7p, Titles II and XVI: Evaluation of Symptoms

in Disability Claims: Assessing the Credibility of an Individual's

Statements;" and replaced it with "SSR 16-3p, Titles II and XVI:

Evaluation of Symptoms in Disability Claims."

[46] 20 CFR 401.55 .

[*] Federal Register Vol. 81,

No. 77, page 23543 removed reference "SSR 96-7p, Titles II and XVI: Evaluation of Symptoms

in Disability Claims: Assessing the Credibility of an Individual's

Statements;" and replaced it with "SSR 16-3p, Titles II and XVI:

Evaluation of Symptoms in Disability Claims."

Back

to Table of Contents

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.